Antivenom Serum Market
1 Study Coverage
1.1 Antivenom Serum Product Introduction
1.2 Global Antivenom Serum Outlook 2017 VS 2022 VS 2028
1.2.1 Global Antivenom Serum Sales in US$ Million for the Year 2017-2028
1.2.2 Global Antivenom Serum Sales in Volume for the Year 2017-2028
1.3 United States Antivenom Serum Outlook 2017 VS 2022 VS 2028
1.3.1 United States Antivenom Serum Sales in US$ Million for the Year 2017-2028
1.3.2 United States Antivenom Serum Sales in Volume for the Year 2017-2028
1.4 Antivenom Serum Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Antivenom Serum in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Antivenom Serum Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Antivenom Serum Market Dynamics
1.5.1 Antivenom Serum Industry Trends
1.5.2 Antivenom Serum Market Drivers
1.5.3 Antivenom Serum Market Challenges
1.5.4 Antivenom Serum Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Antivenom Serum Market Segment by Type
2.1.1 Humans
2.1.2 Animals
2.2 Global Antivenom Serum Market Size by Type
2.2.1 Global Antivenom Serum Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Antivenom Serum Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Antivenom Serum Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Antivenom Serum Market Size by Type
2.3.1 United States Antivenom Serum Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Antivenom Serum Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Antivenom Serum Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Antivenom Serum Market Segment by Application
3.1.1 Monovalent
3.1.2 Polyvalent
3.2 Global Antivenom Serum Market Size by Application
3.2.1 Global Antivenom Serum Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Antivenom Serum Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Antivenom Serum Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Antivenom Serum Market Size by Application
3.3.1 United States Antivenom Serum Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Antivenom Serum Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Antivenom Serum Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Antivenom Serum Competitor Landscape by Company
4.1 Global Antivenom Serum Market Size by Company
4.1.1 Top Global Antivenom Serum Manufacturers Ranked by Revenue (2021)
4.1.2 Global Antivenom Serum Revenue by Manufacturer (2017-2022)
4.1.3 Global Antivenom Serum Sales by Manufacturer (2017-2022)
4.1.4 Global Antivenom Serum Price by Manufacturer (2017-2022)
4.2 Global Antivenom Serum Concentration Ratio (CR)
4.2.1 Antivenom Serum Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Antivenom Serum in 2021
4.2.3 Global Antivenom Serum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Antivenom Serum Manufacturing Base Distribution, Product Type
4.3.1 Global Antivenom Serum Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Antivenom Serum Product Type
4.3.3 Date of International Manufacturers Enter into Antivenom Serum Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Antivenom Serum Market Size by Company
4.5.1 Top Antivenom Serum Players in United States, Ranked by Revenue (2021)
4.5.2 United States Antivenom Serum Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Antivenom Serum Sales by Players (2020, 2021 & 2022)
5 Global Antivenom Serum Market Size by Region
5.1 Global Antivenom Serum Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Antivenom Serum Market Size in Volume by Region (2017-2028)
5.2.1 Global Antivenom Serum Sales in Volume by Region: 2017-2022
5.2.2 Global Antivenom Serum Sales in Volume Forecast by Region (2023-2028)
5.3 Global Antivenom Serum Market Size in Value by Region (2017-2028)
5.3.1 Global Antivenom Serum Sales in Value by Region: 2017-2022
5.3.2 Global Antivenom Serum Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Antivenom Serum Market Size YoY Growth 2017-2028
6.1.2 North America Antivenom Serum Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Antivenom Serum Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Antivenom Serum Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Antivenom Serum Market Size YoY Growth 2017-2028
6.3.2 Europe Antivenom Serum Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Antivenom Serum Market Size YoY Growth 2017-2028
6.4.2 Latin America Antivenom Serum Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Antivenom Serum Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Antivenom Serum Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Merck
7.1.1 Merck Corporation Information
7.1.2 Merck Description and Business Overview
7.1.3 Merck Antivenom Serum Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck Antivenom Serum Products Offered
7.1.5 Merck Recent Development
7.2 Summerland Serums (AU)
7.2.1 Summerland Serums (AU) Corporation Information
7.2.2 Summerland Serums (AU) Description and Business Overview
7.2.3 Summerland Serums (AU) Antivenom Serum Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Summerland Serums (AU) Antivenom Serum Products Offered
7.2.5 Summerland Serums (AU) Recent Development
7.3 Haffkine Bio Pharmaceutical
7.3.1 Haffkine Bio Pharmaceutical Corporation Information
7.3.2 Haffkine Bio Pharmaceutical Description and Business Overview
7.3.3 Haffkine Bio Pharmaceutical Antivenom Serum Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Haffkine Bio Pharmaceutical Antivenom Serum Products Offered
7.3.5 Haffkine Bio Pharmaceutical Recent Development
7.4 MicroPharm
7.4.1 MicroPharm Corporation Information
7.4.2 MicroPharm Description and Business Overview
7.4.3 MicroPharm Antivenom Serum Sales, Revenue and Gross Margin (2017-2022)
7.4.4 MicroPharm Antivenom Serum Products Offered
7.4.5 MicroPharm Recent Development
7.5 CSL (AU)
7.5.1 CSL (AU) Corporation Information
7.5.2 CSL (AU) Description and Business Overview
7.5.3 CSL (AU) Antivenom Serum Sales, Revenue and Gross Margin (2017-2022)
7.5.4 CSL (AU) Antivenom Serum Products Offered
7.5.5 CSL (AU) Recent Development
7.6 SAVP
7.6.1 SAVP Corporation Information
7.6.2 SAVP Description and Business Overview
7.6.3 SAVP Antivenom Serum Sales, Revenue and Gross Margin (2017-2022)
7.6.4 SAVP Antivenom Serum Products Offered
7.6.5 SAVP Recent Development
7.7 Flynn Pharma
7.7.1 Flynn Pharma Corporation Information
7.7.2 Flynn Pharma Description and Business Overview
7.7.3 Flynn Pharma Antivenom Serum Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Flynn Pharma Antivenom Serum Products Offered
7.7.5 Flynn Pharma Recent Development
7.8 Serum
7.8.1 Serum Corporation Information
7.8.2 Serum Description and Business Overview
7.8.3 Serum Antivenom Serum Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Serum Antivenom Serum Products Offered
7.8.5 Serum Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Antivenom Serum Industry Chain Analysis
8.2 Antivenom Serum Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Antivenom Serum Distributors
8.3 Antivenom Serum Production Mode & Process
8.4 Antivenom Serum Sales and Marketing
8.4.1 Antivenom Serum Sales Channels
8.4.2 Antivenom Serum Distributors
8.5 Antivenom Serum Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Antivenom Serum CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Antivenom Serum Market Trends
Table 3. Antivenom Serum Market Drivers
Table 4. Antivenom Serum Market Challenges
Table 5. Antivenom Serum Market Restraints
Table 6. Global Antivenom Serum Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Antivenom Serum Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Antivenom Serum Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Antivenom Serum Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Antivenom Serum Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Antivenom Serum Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Antivenom Serum Revenue Share by Manufacturer, 2017-2022
Table 13. Global Antivenom Serum Sales by Manufacturer, (K Doses), 2017-2022
Table 14. Global Antivenom Serum Sales Share by Manufacturer, 2017-2022
Table 15. Global Antivenom Serum Price by Manufacturer (2017-2022) & (USD/Dose)
Table 16. Global Antivenom Serum Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Antivenom Serum by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivenom Serum as of 2021)
Table 18. Top Players of Antivenom Serum in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Antivenom Serum Product Type
Table 20. Date of International Manufacturers Enter into Antivenom Serum Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Antivenom Serum Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Antivenom Serum Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Antivenom Serum Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Antivenom Serum Sales by Players, (K Doses), 2020, 2021 & 2022
Table 26. United States Antivenom Serum Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Antivenom Serum Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Antivenom Serum Sales in Volume by Region (2017-2022) & (K Doses)
Table 29. Global Antivenom Serum Sales in Volume Forecast by Region (2023-2028) & (K Doses)
Table 30. Global Antivenom Serum Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Antivenom Serum Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Antivenom Serum Sales in Volume by Country (2017-2028) & (K Doses)
Table 33. North America Antivenom Serum Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Antivenom Serum Sales in Volume by Region (2017-2028) & (K Doses)
Table 35. Asia Pacific Antivenom Serum Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Antivenom Serum Sales in Volume by Country (2017-2028) & (K Doses)
Table 37. Europe Antivenom Serum Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Antivenom Serum Sales in Volume by Country (2017-2028) & (K Doses)
Table 39. Latin Americaa Antivenom Serum Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Antivenom Serum Sales in Volume by Country (2017-2028) & (K Doses)
Table 41. Middle East and Africa Antivenom Serum Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Merck Corporation Information
Table 43. Merck Description and Business Overview
Table 44. Merck Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 45. Merck Antivenom Serum Product
Table 46. Merck Recent Development
Table 47. Summerland Serums (AU) Corporation Information
Table 48. Summerland Serums (AU) Description and Business Overview
Table 49. Summerland Serums (AU) Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 50. Summerland Serums (AU) Product
Table 51. Summerland Serums (AU) Recent Development
Table 52. Haffkine Bio Pharmaceutical Corporation Information
Table 53. Haffkine Bio Pharmaceutical Description and Business Overview
Table 54. Haffkine Bio Pharmaceutical Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 55. Haffkine Bio Pharmaceutical Product
Table 56. Haffkine Bio Pharmaceutical Recent Development
Table 57. MicroPharm Corporation Information
Table 58. MicroPharm Description and Business Overview
Table 59. MicroPharm Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 60. MicroPharm Product
Table 61. MicroPharm Recent Development
Table 62. CSL (AU) Corporation Information
Table 63. CSL (AU) Description and Business Overview
Table 64. CSL (AU) Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 65. CSL (AU) Product
Table 66. CSL (AU) Recent Development
Table 67. SAVP Corporation Information
Table 68. SAVP Description and Business Overview
Table 69. SAVP Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 70. SAVP Product
Table 71. SAVP Recent Development
Table 72. Flynn Pharma Corporation Information
Table 73. Flynn Pharma Description and Business Overview
Table 74. Flynn Pharma Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 75. Flynn Pharma Product
Table 76. Flynn Pharma Recent Development
Table 77. Serum Corporation Information
Table 78. Serum Description and Business Overview
Table 79. Serum Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 80. Serum Product
Table 81. Serum Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Antivenom Serum Customers List
Table 85. Antivenom Serum Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivenom Serum Product Picture
Figure 2. Global Antivenom Serum Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Antivenom Serum Market Size 2017-2028 (US$ Million)
Figure 4. Global Antivenom Serum Sales 2017-2028 (K Doses)
Figure 5. United States Antivenom Serum Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Antivenom Serum Market Size 2017-2028 (US$ Million)
Figure 7. United States Antivenom Serum Sales 2017-2028 (K Doses)
Figure 8. United States Antivenom Serum Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Antivenom Serum Market Share in Global, in Volume (K Doses) 2017-2028
Figure 10. Antivenom Serum Report Years Considered
Figure 11. Product Picture of Humans
Figure 12. Product Picture of Animals
Figure 13. Global Antivenom Serum Market Share by Type in 2022 & 2028
Figure 14. Global Antivenom Serum Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Antivenom Serum Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Antivenom Serum Sales by Type (2017-2028) & (K Doses)
Figure 17. Global Antivenom Serum Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Antivenom Serum Price by Type (2017-2028) & (USD/Dose)
Figure 19. United States Antivenom Serum Market Share by Type in 2022 & 2028
Figure 20. United States Antivenom Serum Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Antivenom Serum Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Antivenom Serum Sales by Type (2017-2028) & (K Doses)
Figure 23. United States Antivenom Serum Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Antivenom Serum Price by Type (2017-2028) & (USD/Dose)
Figure 25. Product Picture of Monovalent
Figure 26. Product Picture of Polyvalent
Figure 27. Global Antivenom Serum Market Share by Application in 2022 & 2028
Figure 28. Global Antivenom Serum Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global Antivenom Serum Sales Market Share in Value by Application (2017-2028)
Figure 30. Global Antivenom Serum Sales by Application (2017-2028) & (K Doses)
Figure 31. Global Antivenom Serum Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global Antivenom Serum Price by Application (2017-2028) & (USD/Dose)
Figure 33. United States Antivenom Serum Market Share by Application in 2022 & 2028
Figure 34. United States Antivenom Serum Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States Antivenom Serum Sales Market Share in Value by Application (2017-2028)
Figure 36. United States Antivenom Serum Sales by Application (2017-2028) & (K Doses)
Figure 37. United States Antivenom Serum Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States Antivenom Serum Price by Application (2017-2028) & (USD/Dose)
Figure 39. North America Antivenom Serum Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 40. North America Antivenom Serum Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. U.S. Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe Antivenom Serum Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 44. Europe Antivenom Serum Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific Antivenom Serum Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 51. Asia-Pacific Antivenom Serum Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Taiwan Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Philippines Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America Antivenom Serum Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 63. Latin America Antivenom Serum Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa Antivenom Serum Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 68. Middle East & Africa Antivenom Serum Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. U.A.E Antivenom Serum Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Antivenom Serum Value Chain
Figure 73. Antivenom Serum Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Industry Market Size
